Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -21.92% and Operating profit at -45.07% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 3.92 times
Flat results in Sep 25
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commodity Chemicals
INR 9 Cr (Micro Cap)
NA (Loss Making)
40
0.00%
2.67
-0.56%
5.02
Total Returns (Price + Dividend) 
Latest dividend: 0.9700 per share ex-dividend date: Sep-25-2006
Risk Adjusted Returns v/s 
Returns Beta
News
Are Lime Chemicals latest results good or bad?
Lime Chemicals' latest financial results for Q2 FY26 reflect significant operational challenges. The company reported a net sales figure of ₹1.46 crores, marking a year-on-year decline of 38.66% from ₹2.38 crores in Q2 FY25. This decline continues a troubling trend, as it represents the third consecutive quarter of revenue contraction, with sales now at their lowest level since March 2024. In terms of profitability, Lime Chemicals recorded a net loss of ₹0.16 crores, a stark contrast to the profit of ₹0.03 crores in the previous quarter (Q1 FY26). The operating margin remained negative at -10.96%, indicating ongoing difficulties in managing costs relative to revenue. This negative operating margin has persisted for five of the last seven quarters, underscoring fundamental issues within the company's operational framework. The balance sheet shows signs of strain, with shareholder funds at just ₹1.94 crore...
Read MoreHow has been the historical performance of Lime Chemicals?
Answer: The historical performance of Lime Chemicals shows a declining trend in net sales and profitability over the years, with significant fluctuations in various financial metrics. Breakdown: Lime Chemicals has experienced a steady decline in net sales from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025. The total operating income followed a similar trend, decreasing from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025. The raw material costs and purchase of finished goods have also varied, with raw material costs rising to INR 3.19 crore in March 2025 from INR 0.44 crore in March 2023. The company reported an operating profit margin that turned negative in recent years, reaching -1.34% in March 2025, compared to a positive margin of 7.87% in March 2019. Profit before tax showed a decline, with a profit of INR 0.24 crore in March 2025, down from INR 3.08 crore in March 2023....
Read More
Lime Chemicals Q2 FY26: Mounting Losses Deepen as Revenue Plummets 39%
Lime Chemicals Ltd., a Maharashtra-based micro-cap manufacturer of calcium carbonate products, reported a troubling Q2 FY26 performance that underscores the company's deepening operational distress. The quarter ended September 2025 saw the company post a net loss of ₹0.16 crores, marking a sharp deterioration from the marginal ₹0.03 crores profit in Q1 FY26 and a year-on-year decline from the ₹0.05 crores loss in Q2 FY25.
Read More Announcements 
Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th November 2025
14-Nov-2025 | Source : BSEOutcome of the Board Meeting held on 14th November is attached herewith.
Un-Audited Financial Results For The Quarter Ended On 30Th September 2025
14-Nov-2025 | Source : BSEThe un-audited financial results for the quarter ended on 30th September 2025 approved on 14th November 2025 is attached herewith.
Board Meeting Intimation for Board Meeting On 14Th November 2025
06-Nov-2025 | Source : BSELime Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve A meeting of Board of Directors will be held on Friday the 14th November 2025 to consider and approve un-audited financial results for the quarter and half year ended on 30th September 2025.
Corporate Actions 
No Upcoming Board Meetings
Lime Chemicals Ltd has declared 12% dividend, ex-date: 25 Sep 06
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 5 Schemes (0.05%)
Held by 1 FIIs (2.35%)
Rahim Ahmed Dawoodani (10.62%)
Devanshi Parimal Merchant (12.3%)
63.96%
Quarterly Results Snapshot (Standalone) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is -38.66% vs 5.78% in Sep 2024
YoY Growth in quarter ended Sep 2025 is -220.00% vs 54.55% in Sep 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -38.93% vs -1.45% in Sep 2024
Growth in half year ended Sep 2025 is -230.00% vs 131.25% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -0.87% vs -33.09% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 142.11% vs -113.10% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -7.46% vs -32.49% in Mar 2024
YoY Growth in year ended Mar 2025 is 144.90% vs -117.75% in Mar 2024






